Graeme J. Poston

15.0k total citations · 5 hit papers
142 papers, 9.3k citations indexed

About

Graeme J. Poston is a scholar working on Oncology, Hepatology and Surgery. According to data from OpenAlex, Graeme J. Poston has authored 142 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Oncology, 82 papers in Hepatology and 58 papers in Surgery. Recurrent topics in Graeme J. Poston's work include Hepatocellular Carcinoma Treatment and Prognosis (82 papers), Colorectal Cancer Treatments and Studies (55 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (41 papers). Graeme J. Poston is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (82 papers), Colorectal Cancer Treatments and Studies (55 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (41 papers). Graeme J. Poston collaborates with scholars based in United Kingdom, France and United States. Graeme J. Poston's co-authors include John Primrose, Eric Van Cutsem, Stephen W. Fenwick, Bernard Nordlinger, Philippe Rougier, Thomas Gruenberger, Bengt Glimelius, Robert Jones, Wolf O. Bechstein and Euan Walpole and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Graeme J. Poston

137 papers receiving 9.1k citations

Hit Papers

Perioperative chemotherapy with FOLFOX4 and surgery versu... 2006 2026 2012 2019 2008 2013 2006 2012 2015 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
    2008 1.4k citations Graeme J. Poston, John Primrose et al. profile →
  2. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
    2013 853 citations Graeme J. Poston, John Primrose et al. The Lancet Oncology profile →
  3. Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies
    2006 649 citations John Primrose, Graeme J. Poston et al. profile →
  4. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors
    2012 488 citations John Primrose, Graeme J. Poston et al. profile →
  5. Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus
    2015 376 citations René Adam, Joan Figueras et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Graeme J. Poston United Kingdom 42 6.4k 5.5k 3.5k 2.4k 815 142 9.3k
Thomas Gruenberger Austria 46 6.7k 1.0× 6.3k 1.2× 3.8k 1.1× 2.8k 1.1× 775 1.0× 192 10.2k
Luca Aldrighetti Italy 52 5.6k 0.9× 4.8k 0.9× 7.0k 2.0× 4.1k 1.7× 371 0.5× 405 10.8k
Karim Boudjéma France 48 2.9k 0.5× 5.0k 0.9× 4.8k 1.3× 1.9k 0.8× 482 0.6× 292 8.9k
Philippe Bachellier France 44 5.3k 0.8× 4.1k 0.8× 4.5k 1.3× 2.5k 1.0× 335 0.4× 229 8.1k
David A. Kooby United States 56 5.8k 0.9× 2.0k 0.4× 5.1k 1.5× 3.6k 1.5× 419 0.5× 310 10.5k
Johannes H.W. de Wilt Netherlands 51 5.9k 0.9× 1.2k 0.2× 4.2k 1.2× 2.1k 0.9× 652 0.8× 320 9.3k
Hiroshi Imamura Japan 49 2.4k 0.4× 7.1k 1.3× 5.8k 1.6× 2.1k 0.8× 495 0.6× 300 10.6k
Matteo Donadon Italy 41 2.4k 0.4× 3.9k 0.7× 2.5k 0.7× 1.1k 0.4× 482 0.6× 167 6.0k
W. Y. Lau Hong Kong 42 1.6k 0.2× 3.4k 0.6× 3.4k 1.0× 2.3k 0.9× 685 0.8× 135 6.8k
Marco Montorsi Italy 45 2.5k 0.4× 1.7k 0.3× 2.7k 0.8× 1.4k 0.6× 309 0.4× 187 5.6k

Countries citing papers authored by Graeme J. Poston

Since Specialization
Citations

This map shows the geographic impact of Graeme J. Poston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graeme J. Poston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graeme J. Poston more than expected).

Fields of papers citing papers by Graeme J. Poston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graeme J. Poston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graeme J. Poston. The network helps show where Graeme J. Poston may publish in the future.

Co-authorship network of co-authors of Graeme J. Poston

This figure shows the co-authorship network connecting the top 25 collaborators of Graeme J. Poston. A scholar is included among the top collaborators of Graeme J. Poston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graeme J. Poston. Graeme J. Poston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haldenby, Sam, Anna Fowler, Katie Bullock, et al.. (2023). Genomic profiling of idiopathic peri-hilar cholangiocarcinoma reveals new targets and mutational pathways. Scientific Reports. 13(1). 6681–6681. 5 indexed citations
2.
Kalaiselvan, R, Kaitlyn Wong, Nasim Ali, et al.. (2018). Impact of centralization of services on outcomes in a rare tumour: Retroperitoneal sarcomas. European Journal of Surgical Oncology. 45(2). 249–253. 17 indexed citations
3.
Dupré, Aurélien, Robert Jones, Alex Parker, et al.. (2018). Validation of clinical prognostic scores for patients treated with curative‐intent for recurrent colorectal liver metastases. Journal of Surgical Oncology. 117(6). 1330–1336. 14 indexed citations
4.
Bird, N., et al.. (2018). Meta-analysis of prognostic factors for overall survival in patients with resected hilar cholangiocarcinoma. British journal of surgery. 105(11). 1408–1416. 40 indexed citations
5.
Dupré, Aurélien, Robert Jones, Rafael Díaz-Nieto, et al.. (2017). Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection. European Journal of Surgical Oncology. 43(10). 1901–1907. 41 indexed citations
6.
Elmasry, Mohamed, et al.. (2016). The risk of malignancy in ultrasound detected gallbladder polyps: A systematic review. International Journal of Surgery. 33. 28–35. 88 indexed citations
7.
Jones, Robert, Hafiz Malik, Stephen W. Fenwick, et al.. (2016). PARAGON II – A single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer. European Journal of Surgical Oncology. 42(12). 1866–1872. 28 indexed citations
8.
Balch, Charles M. & Graeme J. Poston. (2016). Training a new generation of surgical oncologists worldwide. The Lancet Oncology. 17(6). 700–701. 3 indexed citations
9.
Zwan, Jan Maarten van der, Annalisa Trama, R. Otter, et al.. (2013). Rare neuroendocrine tumours: Results of the surveillance of rare cancers in Europe project. European Journal of Cancer. 49(11). 2565–2578. 87 indexed citations
10.
Yip, Vincent, Dhanny Gomez, Sean Brown, et al.. (2013). Management of incidental and suspicious gallbladder cancer: focus on early referral to a tertiary centre. HPB. 16(7). 641–647. 26 indexed citations
11.
Stättner, Stefan, Robert Jones, Vincent Yip, et al.. (2013). Microwave ablation with or without resection for colorectal liver metastases. European Journal of Surgical Oncology. 39(8). 844–849. 54 indexed citations
12.
Steele, Islay, R. Dimaline, Graeme J. Poston, et al.. (2012). Correlation between a short-term intravenous octreotide suppression test and response to antrectomy in patients with type-1 gastric neuroendocrine tumours. European Journal of Gastroenterology & Hepatology. 25(4). 474–481. 11 indexed citations
13.
Adam, René, Prashant Bhangui, Graeme J. Poston, et al.. (2010). Is Perioperative Chemotherapy Useful for Solitary, Metachronous, Colorectal Liver Metastases?. Annals of Surgery. 252(5). 774–787. 131 indexed citations
14.
Poston, Graeme J., et al.. (2007). Carcinoid syndrome. European Journal of Surgical Oncology. 34(3). 289–296. 20 indexed citations
15.
Vinjamuri, Sobhan, et al.. (2001). 131I-MIBG radionuclide therapy is safe and cost-effective in the control of symptoms of the carcinoid syndrome. European Journal of Surgical Oncology. 27(4). 404–408. 43 indexed citations
16.
Poston, Graeme J., I.S. Benjamin, Tom Diamond, et al.. (2001). Costs of neoadjuvant chemotherapy and surgery in patients with liver metastases from advanced colorectal cancer. Journal of Medical Economics. 4(1-4). 167–177. 6 indexed citations
17.
Poston, Graeme J., et al.. (2001). Lessons from Japan – endoscopic management of early gastric and oesophageal cancer. European Journal of Surgical Oncology. 27(1). 9–16. 13 indexed citations
18.
Wong, Kenneth K., et al.. (1991). Postprandial hypergastrinaemia in patients with colorectal cancer.. Gut. 32(11). 1352–1354. 52 indexed citations
19.
Poston, Graeme J., Courtney M. Townsend, Srinivasan Rajaraman, James C. Thompson, & Pomila Singh. (1990). Effect of Somatostatin and Tamoxifen on the Growth of Human Pancreatic Cancers in Nude Mice. Pancreas. 5(2). 151–157. 24 indexed citations
20.
Lawrence, John, et al.. (1988). Hyperplasia of colonic mucosa and pancreas after ileocecal resection is not caused by gastrin. 39. 177–179. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Gruenberger Breakdown of academic impact, for papers by Luca Aldrighetti Breakdown of academic impact, for papers by Karim Boudjéma Breakdown of academic impact, for papers by Philippe Bachellier Breakdown of academic impact, for papers by David A. Kooby Breakdown of academic impact, for papers by Johannes H.W. de Wilt Breakdown of academic impact, for papers by Hiroshi Imamura Breakdown of academic impact, for papers by Matteo Donadon Breakdown of academic impact, for papers by W. Y. Lau Breakdown of academic impact, for papers by Marco Montorsi
Rankless by CCL
2026